Results 181 to 190 of about 692,682 (292)
Use of Glargine and Lente Insulins in Cats with Diabetes Mellitus [PDF]
, 2006 Kelli E. Weaver +4 more
openalex +1 more source
The Modified Recombinant Proinsulin: A Simple and Efficient Way to Produce Insulin Glargine in E. coli [PDF]
, 2021 Seyyedeh khadijeh Hosseini oula +2 more
openalex +1 more source
Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy [PDF]
, 2012 J. Lepercq +6 more
openalex +1 more source
Management of feline diabetes mellitus: update and challenges [PDF]
, 2017 PòsterJun
Caparrós Vallcorba, Cristina +1 more
core
Concentrated insulins: the new basal insulins
Therapeutics and Clinical Risk Management, 2016 Elizabeth M Lamos,1 Lisa M Younk,2 Stephen N Davis3 1Division of Endocrinology, Diabetes and Nutrition, 2Department of Medicine, University of Maryland School of Medicine, 3Department of Medicine, University of Maryland Medical Center, Baltimore, MD ...
Lamos EM, Younk LM, Davis SN
doaj
Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 771-774, January 2026.
Ulrike Glatz +16 more
wiley +1 more source
Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH–IGF1–IGFBP axis in patients with type 1 diabetes [PDF]
, 2014 Zhulin Ma +4 more
openalex +1 more source
Economic analysis of Lixisenatide in Diabetes Mellitus Type 2
Качественная клиническая практика, 2018 Usage of glucagon like peptide-1 receptors’ agonists (aGLP-1) is a new step in the treatment of Diabetes Mellitus Type 2 (DM 2). General attractive effects are positive effect on bodyweight, lower risk of hypoglycemia, compliance and possibility of ...
A. S. Kolbin +5 more
doaj